227 related articles for article (PubMed ID: 22111588)
81. Cytoplasmic polyadenylation-mediated translational control of maternal mRNAs directs maternal-to-zygotic transition.
Winata CL; Łapiński M; Pryszcz L; Vaz C; Bin Ismail MH; Nama S; Hajan HS; Lee SGP; Korzh V; Sampath P; Tanavde V; Mathavan S
Development; 2018 Jan; 145(1):. PubMed ID: 29229769
[TBL] [Abstract][Full Text] [Related]
82. The Impact of the C-Terminal Region on the Interaction of Topoisomerase II Alpha with Mitotic Chromatin.
Antoniou-Kourounioti M; Mimmack ML; Porter ACG; Farr CJ
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871006
[TBL] [Abstract][Full Text] [Related]
83. Triple negative breast cancer--current status and prospective targeted treatment based on HER1 (EGFR), TOP2A and C-MYC gene assessment.
Bouchalova K; Cizkova M; Cwiertka K; Trojanec R; Hajduch M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):13-7. PubMed ID: 19365520
[TBL] [Abstract][Full Text] [Related]
84. The value of TOP2A, EZH2 and paxillin expression as markers of aggressive breast cancer: relationship with other prognostic factors.
Panousis D; Patsouris E; Lagoudianakis E; Pappas A; Kyriakidou V; Voulgaris Z; Xepapadakis G; Manouras A; Athanassiadou AM; Athanassiadou P
Eur J Gynaecol Oncol; 2011; 32(2):156-9. PubMed ID: 21614903
[TBL] [Abstract][Full Text] [Related]
85. A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification.
Tarpgaard LS; Qvortrup C; Nygård SB; Nielsen SL; Andersen DR; Jensen NF; Stenvang J; Detlefsen S; Brünner N; Pfeiffer P
BMC Cancer; 2016 Feb; 16():91. PubMed ID: 26867764
[TBL] [Abstract][Full Text] [Related]
86. Chromosome breakage is regulated by the interaction of the BLM helicase and topoisomerase IIalpha.
Russell B; Bhattacharyya S; Keirsey J; Sandy A; Grierson P; Perchiniak E; Kavecansky J; Acharya S; Groden J
Cancer Res; 2011 Jan; 71(2):561-71. PubMed ID: 21224348
[TBL] [Abstract][Full Text] [Related]
87. Topoisomerase II-alfa gene as a predictive marker of response to anthracyclines in breast cancer.
Almeida D; Gerhard R; Leitão D; Davilla C; Damasceno M; Schmitt F
Pathol Res Pract; 2014 Oct; 210(10):675-9. PubMed ID: 25042383
[TBL] [Abstract][Full Text] [Related]
88. TOP2A deficiency leads to human recurrent spontaneous abortion and growth retardation of mouse pre-implantation embryos.
Duan Y; Fu H; Huang J; Yin N; Liu L; Liu X
Mol Med; 2022 Dec; 28(1):165. PubMed ID: 36585615
[TBL] [Abstract][Full Text] [Related]
89. Topoisomerase II is required for mitoxantrone to signal nuclear factor kappa B activation in HL60 cells.
Boland MP; Fitzgerald KA; O'Neill LA
J Biol Chem; 2000 Aug; 275(33):25231-8. PubMed ID: 10940316
[TBL] [Abstract][Full Text] [Related]
90. p53 Maintains Genomic Stability by Preventing Interference between Transcription and Replication.
Yeo CQX; Alexander I; Lin Z; Lim S; Aning OA; Kumar R; Sangthongpitag K; Pendharkar V; Ho VHB; Cheok CF
Cell Rep; 2016 Apr; 15(1):132-146. PubMed ID: 27052176
[TBL] [Abstract][Full Text] [Related]
91. Phase separation of Ddx3xb helicase regulates maternal-to-zygotic transition in zebrafish.
Shi B; Heng J; Zhou JY; Yang Y; Zhang WY; Koziol MJ; Zhao YL; Li P; Liu F; Yang YG
Cell Res; 2022 Aug; 32(8):715-728. PubMed ID: 35661831
[TBL] [Abstract][Full Text] [Related]
92. Mutational analysis of dishevelled genes in zebrafish reveals distinct functions in embryonic patterning and gastrulation cell movements.
Xing YY; Cheng XN; Li YL; Zhang C; Saquet A; Liu YY; Shao M; Shi DL
PLoS Genet; 2018 Aug; 14(8):e1007551. PubMed ID: 30080849
[TBL] [Abstract][Full Text] [Related]
93. [Expression of topoisomerase II alpha in human colorectal carcinoma and its significance].
Yang FD; Jia ZL
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1959-61, 1964. PubMed ID: 20813715
[TBL] [Abstract][Full Text] [Related]
94. RRM1, TUBB3, TOP2A, CYP19A1, CYP2D6: Difference between mRNA and protein expression in predicting prognosis of breast cancer patients.
Xu YC; Zhang FC; Li JJ; Dai JQ; Liu Q; Tang L; Ma Y; Xu Q; Lin XL; Fan HB; Wang HX
Oncol Rep; 2015 Oct; 34(4):1883-94. PubMed ID: 26252353
[TBL] [Abstract][Full Text] [Related]
95. Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.
Amirnasr A; Verdijk RM; van Kuijk PF; Taal W; Sleijfer S; Wiemer EAC
PLoS One; 2017; 12(8):e0183155. PubMed ID: 28813519
[TBL] [Abstract][Full Text] [Related]
96. Untangling the roles of TOP2A and TOP2B in transcription and cancer.
Uusküla-Reimand L; Wilson MD
Sci Adv; 2022 Nov; 8(44):eadd4920. PubMed ID: 36322662
[TBL] [Abstract][Full Text] [Related]
97. TOP2B's contributions to transcription.
Austin CA; Cowell IG; Khazeem MM; Lok D; Ng HT
Biochem Soc Trans; 2021 Dec; 49(6):2483-2493. PubMed ID: 34747992
[TBL] [Abstract][Full Text] [Related]
98. Nucleolar translocation of human DNA topoisomerase II by ATP depletion and its disruption by the RNA polymerase I inhibitor BMH-21.
Morotomi-Yano K; Yano KI
Sci Rep; 2021 Nov; 11(1):21533. PubMed ID: 34728715
[TBL] [Abstract][Full Text] [Related]
99. Mutations in TOP2B cause autosomal-dominant hereditary hearing loss via inhibition of the PI3K-Akt signalling pathway.
Xia W; Hu J; Ma J; Huang J; Jing T; Deng L; Zhang J; Jiang N; Ma D; Ma Z
FEBS Lett; 2019 Aug; 593(15):2008-2018. PubMed ID: 31198993
[TBL] [Abstract][Full Text] [Related]
100. Revisiting TOP2B-related phenotypes: Three new cases and literature review.
Çepni E; Börklü E; Avcı Ş; Kalaycı T; Eraslan S; Kayserili H
Clin Genet; 2023 Aug; 104(2):251-258. PubMed ID: 37068767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
